Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Revvity

RVTY Healthcare Unknown Updated July 31, 2026
$112.50
52W $81.22 – $118.30
52/100
$12.55B
53.6
1.09
AI Committee Verdict
Watch
Conviction: Moderate · 67% agreement · 6 analysts
+3.2%
-25.8%
0.13:1
Moderate

Is RVTY Bullish or Bearish?

Mixed. Innellis AI committee rates Revvity (RVTY) Watch with a composite score of 52/100 , based on 6 analysts with 67% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +8.00 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -12.00 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

Some positive signals exist — price structure making higher highs and higher lows — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.

Bull & Bear Case

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 52.8 is expensive by classic value standards — Value
  • ROE of only 3.3% -- cheap may mean cheap for a reason — Value
  • EPS declining -10.7% YoY despite any revenue growth — Growth
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
52/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 75%
of 93 Healthcare peers
Value Analyst neutral
44 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 52.8 is expensive by classic value standards
Growth Analyst neutral
44 / 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -10.7% YoY despite any revenue growth
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
61 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 52.7 to 52.0.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • News Analyst: stance neutral->bullish; score 58->61 (+3).
  • Portfolio Manager: +2 bearish signal(s).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
55.4
Neutral
MACD Histogram
-0.179
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$83.50
Resistance
$116.13
Bollinger %B
0.68
Inside Bands
Price vs Moving Averages
EMA 9
$111.71 Above
EMA 21
$110.48 Above
EMA 50
$106.54 Above
EMA 200
$99.45 Above

Fundamental Analysis

Valuation
65
Growth
48
Profitability
0
Financial Health
88
Cash Flow
37
Valuation
P/E Ratio 53.6×
P/B Ratio 1.75×
PEG Ratio -3.15
Dividend Yield 0.00%
52W High $118.30
52W Low $81.22
Quality & Growth
ROE 3.3%
ROA 2.0%
Gross Margin 51.4%
Operating Margin 12.4%
Revenue Growth YoY
Debt / Equity 0.47
AI Fundamental Assessment
P/E ratio of 53.6 (rich relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of -3.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.0%; Return on assets of 0.0%; Net margin of 0.1%; Gross margin of 0.5%; Current ratio of 1.72 (healthy short-term liquidity); Debt-to-equity of 0.47; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (4.41); Most recent quarter beat estimates by 2.3%; 4 consecutive earnings beats; EPS growth decelerating (+44.1% -> -37.6% QoQ); Analyst estimates falling over recent quarters
Get the Full RVTY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore RVTY Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime